BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1655341)

  • 1. Kidney renin gene expression after renin inhibition in the marmoset.
    Kitami Y; Hiwada K; Murakami E; Iwata T; Muneta S; Kokubu T
    Clin Sci (Lond); 1991 Sep; 81(3):387-92. PubMed ID: 1655341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renin inhibitor, ES-8891, on renal renin secretion and storage in the marmoset: comparison with captopril.
    Ii Y; Murakami E; Hiwada K
    J Hypertens; 1991 Dec; 9(12):1119-25. PubMed ID: 1663967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the renin inhibitor ES-1005 on the expression of the kidney renin gene in sodium-depleted marmosets.
    Kitami Y; Hiwada K; Murakami E; Muneta S; Kokubu T
    J Hypertens; 1990 Dec; 8(12):1143-6. PubMed ID: 1962804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of renin inhibitor (ES-1005) on expression of the kidney renin gene in sodium-depleted marmosets].
    Kitami Y
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):427-33. PubMed ID: 2198366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ES-8891, an orally active inhibitor of human renin.
    Kokubu T; Hiwada K; Murakami E; Muneta S; Kitami Y; Salmon PF
    Hypertension; 1990 Jun; 15(6 Pt 2):909-13. PubMed ID: 2112512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin inhibitors on the expression of kidney renin gene and tissue renin-like activity.
    Kokubu T; Kitami Y; Muneta S; Murakami E; Hiwada K
    J Hypertens Suppl; 1989 Apr; 7(2):S29-32. PubMed ID: 2666610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly potent and long-acting oral inhibitor of human renin.
    Hiwada K; Kokubu T; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of components of the RAS during prolonged blockade at different levels in primates.
    Samani NJ; Cumin F; Kelly M; Wood JM
    Am J Physiol; 1994 Oct; 267(4 Pt 1):E612-9. PubMed ID: 7943312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
    Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA.
    Nakamura N; Soubrier F; Menard J; Panthier JJ; Rougeon F; Corvol P
    Hypertension; 1985; 7(6 Pt 1):855-9. PubMed ID: 3908312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypotensive action of human renin inhibitor KRI-1314 in the common marmoset].
    Saitoh H; Etoh Y; Murakami M; Kubota T; Miyazaki M
    Nihon Yakurigaku Zasshi; 1994 Apr; 103(4):161-73. PubMed ID: 8175079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic infusion of angiotensin II on renin and blood pressure in the late-gestation fetal sheep.
    Stanley JR; Giammattei CE; Sheikh AU; Green JL; Zehnder T; Rose JC
    Am J Obstet Gynecol; 1997 Apr; 176(4):931-7. PubMed ID: 9125623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical effects of prolonged renin inhibition in marmosets.
    Wood JM; Jobber RA; Baum HP; de Gasparo M; Nussberger J
    J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
    Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
    Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
    Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert HD; Luther R; Brunner HR
    Hypertension; 1989 Jun; 13(6 Pt 2):941-7. PubMed ID: 2661434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans.
    Cordero P; Fisher ND; Moore TJ; Gleason R; Williams GH; Hollenberg NK
    Hypertension; 1991 Apr; 17(4):510-6. PubMed ID: 2013477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL; Cheng HF; Harris RC
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of acute and chronic renin inhibition in marmosets.
    Wood JM; Baum HP; Forgiarini P; Gulati N; Jobber RA; Neisius D; Hofbauer KG
    J Hypertens Suppl; 1989 Apr; 7(2):S37-42. PubMed ID: 2547039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ro 42-5892 is a potent orally active renin inhibitor in primates.
    Fischli W; Clozel JP; el Amrani K; Wostl W; Neidhart W; Stadler H; Branca Q
    Hypertension; 1991 Jul; 18(1):22-31. PubMed ID: 1830563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.